Beta-receptor blocking agents and glaucoma; timolol in eye drops
Ros, F.E.; Dake, C.L.; Innemee, H.C.; van Zwieten, P.A.
Nederlands Tijdschrift Voor Geneeskunde 125(11): 422-425
1981
ISSN/ISBN: 0028-2162 PMID: 7219582 Document Number: 180041
Document emailed within 1 workday
Related Documents
Kovacić, Z.; Ivanisević, M.; Stanić, R.; Bojić, L.; Capkun, V.; Rogosića, V. 2007: Additive therapy with carboanhydrase inhibitors for open angle glaucoma previously treated with timolol 0.5% drops Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 61(4): 417-419Stienstra, R.; de Leeuw, P.W. 1980: Anesthesia in patients under treatment with beta-receptor blocking agents Nederlands Tijdschrift Voor Geneeskunde 124(44): 1878-1881
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136
Lenders, J.W.; Thien, T. 1984: Cold hands and feet in the treatment of hypertension with beta receptor blocking agents Nederlands Tijdschrift Voor Geneeskunde 128(49): 2318-2321
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Bellomo, G.; Santucci, S.; Murrone, A.; Santambrogio, L.; Gennari, M.; Stangoni, G. 1988: Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity Panminerva Medica 30(4): 236-239
Singh, K.P. 1979: Modification of hexobarbitone sodium-induced hynosis in mice by beta adrenergic receptor blocking agents Indian Journal of Physiology and Pharmacology 23(1): 52-54
Hoffmann, J.; Schrey, A.; Grund, R.; Forst, T. 1981: Combination of beta-receptor blocking agents and saluretica in outpatient treatment of hypertension. Results of a comparative study Münchener Medizinische Wochenschrift 123(12): 483-488
Pyörälä, K.; Mattila, S.; Leirisalo, M.; Toivonen, S. 1976: The antihypertensive effect of a new beta-blocking drug timolol in combination with hydrochlorothiazide Duodecim; Laaketieteellinen Aikakauskirja 92(11): 588-596
Mäurer, W.; Kuhn, H.; Breithardt, G.; Kübler, W. 1975: Adrenaline, noradrenaline, and adenosine 3',5'-monophosphate levels in plasma of healthy persons during ergometric work with and without beta-receptor blocking agents Recent Advances in Studies on Cardiac Structure and Metabolism 7: 369-374
Metheetrairut, A.; Leumsamran, P.; Rojananin, S.; Kitnarong, N. 2012: A comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucoma Journal of the Medical Association of Thailand 95(Suppl 4): S116-S122
At'kov, O.I.; Krol, V.A.; Chumburidze, V.B. 1977: Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease Terapevticheskii Arkhiv 49(10): 57-60
Miki, H. 1983: Effect of befunolol ophthalmic solution, alpha, beta-adrenergic blocking agent, on secondary glaucoma Nippon Ganka Gakkai Zasshi 87(1): 1-13
Serratrice, G.; Godde, J.L.; Schiano, A. 1977: Treatment of erythromelalgia with beta-blocking agents La Nouvelle Presse Medicale 6(42): 3973
Duan, H.J.; Fang, H.J.; Zhou, T.H.; Chen, C. 1991: Studies on the analysis of beta-blocking agents Yao Xue Xue Bao 26(5): 351-357
Torsti, P. 1980: Use of beta blocking agents after myocardial infarction Duodecim; Laaketieteellinen Aikakauskirja 96(4): 282-283
Jackson, E.A.; Sullman, S.A. 1984: Comparative review of beta-blocking agents Connecticut Medicine 48(4): 213-215